Prospects of using the mediterranean diet in the treatment of inflammatory bowel diseases
https://doi.org/10.21508/1027-4065-2025-70-6-21-28
Abstract
For many years, the Mediterranean diet has been considered an exemplary regime for maintaining health and preventing chronic diseases. The results of modern research show that following the Mediterranean diet is associated with improved clinical symptoms, quality of life, and lower mortality rates in patients with inflammatory bowel diseases. The aim of the systematic review was to present data from recent studies on the role of components of the Mediterranean diet in relation to their effect on the course of inflammatory bowel diseases. The Mediterranean diet is widely known for its health benefits, but these effects may not be suitable for all patients with inflammatory bowel diseases due to the high variability of the disease course. Studying the complex interrelationships between lifestyle, nutrients, and pathogenetic aspects of inflammatory bowel diseases will allow us to develop a personalized treatment strategy for the disease in the future.
About the Authors
A. V. Nalyotov
Gorky Donetsk State Medical University
Russian Federation
Russian Federation
283003, Donetsk
A. I. Khavkin
Research Clinical Institute of Childhood, Ministry of Health of the Moscow Region ; Belgorod State National Research University
Russian Federation
Russian Federation
115093, Moscow
308015, Belgorod
A. N. Matsynin
Gorky Donetsk State Medical University
Russian Federation
Russian Federation
283003, Donetsk
References
1. Khavkin A.I., Nalyotov A.V., Marchenko N.A., Slutskin V.E. Effectiveness of enteral nutrition in the treatment of inflammatory bowel diseases in children: a modern view of the problem. Voprosy prakticheskoj pediatrii. 2024; 19 (3): 65– 72. (in Russ). DOI: 10.20953/1817-7646-2024-3-65-72
2. Khavkin A.I., Nalyotov A.V., Shumilov P.V., Sitkin S.I., Marchenko N.A. Dietary aspects in the treatment of inflammatory bowel disease. Voprosy detskoj dietologii. 2024; 22 (1): 51–62. (in Russ). DOI: 10.20953/1727-5784-2024-1-51-62
3. Godny L., Dotan I. Is the Mediterranean diet in inflammatory bowel diseases ready for prime time? J. Can. Assoc. Gastroenterol. 2024; 7: 97–103. DOI: 10.1093/jcag/gwad041
4. Lewis J.D., Sandler R.S., Brotherton C., Brensinger C., Li H., Kappelman M.D., et al. A randomized trial comparing the specific carbohydrate diet to a Mediterranean diet in adults with Crohn’s disease. Gastroenterology. 2021; 161: 837–852.e9. DOI: 10.1053/j.gastro.2021.05.047
5. Hashash J.G., Elkins J., Lewis J.D., Binion D.G. AGA clinical practice update on diet and nutritional therapies in patients with inflammatory bowel disease: expert review. Gastroenterology. 2024; 166: 521–532. DOI: 10.1053/j.gastro.2023.11.303
6. Khavkin A.I., Nalyotov A.V., Matsynina M.A. Anti-inflammatory effects of olive oil and its components. Prospects of application in the treatment of inflammatory bowel diseases. Pediatricheskaja farmakologija. 2024; 21 (3): 249–255. (in Russ). DOI: 10.15690/pf.v21i3.2754
7. Chicco F., Magrì S., Cingolani A., Paduano D., Pesenti M., Zara F., et al. Multidimensional impact of Mediterranean diet on IBD patients. Inflamm. Bowel Dis. 2021; 27: 1–9. DOI: 10.1093/ibd/izaa097
8. Papada E., Amerikanou C., Forbes A., Kaliora A.C. Adherence to Mediterranean diet in Crohn’s disease. Eur. J. Nutr. 2020; 59: 1115–1121. DOI: 10.1007/s00394-019-01972-z
9. Godny L., Reshef L., Pfeffer-Gik T., Goren I., Yanai H., Tulchinsky H. et al. Adherence to the Mediterranean diet isassociated with decreased fecal calprotectin in patients with ulcerative colitis after pouch surgery. Eur. J. Nutr. 2020; 59: 3183–3190. DOI: 10.1007/s00394-019-02158-3
10. Vrdoljak J., Vilovi´c M., Živkovi´c P., Tadin Hadjina I., Rušić D., Bukić J. et al. Mediterranean diet adherence and dietary attitudes in patients with inflammatory bowel disease. Nutrients. 2020; 12: 3429. DOI: 10.3390/nu12113429
11. Khavkin A.I., Nalyotov A.V., Kuropyatnik P.I. Fruits and their effect on the state of the intestinal microbiota and intestinal motility. Voprosy dietologii. 2024; 14 (3): 49–56. (in Russ). DOI: 10.20953/2224-5448-2024-3-49-56
12. Khavkin A.I., Nalyotov A.V., Shumilov P.V., Sitkin S.I. The effectiveness of dietary fiber in inflammatory bowel disease. Voprosy detskoj dietologii. 2024; 22 (2): 74–81. (in Russ). DOI: 10.20953/1727-5784-2024-2-74-81
13. Rodríguez-Morató J., Matthan N.R., Liu J., de la Torre R., Chen C-YO. Cranberries attenuate animal-based diet-induced changes in microbiota composition and functionality: A randomized crossover-controlled feeding trial. J. Nutr. Biochem. 2018; 62: 76–86. DOI: 10.1016/j.jnutbio.2018.08.019
14. Chan A.O., Leung G., Tong T., Wong N.Yh. Increasing dietary fiber intake in terms of kiwifruit improves constipation in Chinese patients. World J. Gastroenterol. 2007; 13: 4771–4775. DOI: 10.3748/wjg.v13.i35.4771
15. Chang C.C., Lin Y.T., Lu Y.T., Liu Yu.S., Liu J-F. Kiwifruit improves bowel function in patients with irritable bowel syndrome with constipation. Asia Pac. J. Clin. Nutr. 2010; 19: 451–457
16. Wilson R., Willis J., Gearry R.B., Hughes A., Lawley B., Skidmore P., et al. SunGold Kiwifruit supplementation of individuals with prediabetes alters gut microbiota and improves vitamin C status, anthropometric and clinical markers. Nutrients. 2018; 10 (7): 895. DOI: 10.3390/nu10070895
17. Baek H.I., Ha K.C., Kim H.M., Choi E-K., Park E-O., Park B.H., et al. Randomized, double-blind, placebocontrolled trial of Ficus carica paste for the management of functional constipation. Asia Pac. J. Clin. Nutr. 2016; 25: 487–496. DOI: 10.6133/apjcn.092015.06
18. Akasheva D.U., Drapkina O.M. Mediterranean Diet: Origin History, Main Components, Evidence of Benefits and Feasibility to Adapt to the Russian Reality. Racional’naja Farmakoterapija v Kardiologii. 2020; 16 (2): 307–316. (in Russ). DOI: 10.20996/1819-6446-2020-04-03
19. Albenberg L., Brensinger C.M., Wu Q., Gilroy E., Kappelman M.D., Sandler R.S. et al. A diet low in red and processed meat does not reduce rate of Crohn’s disease flares. Gastroenterology. 2019; 157: 128–136.e5. DOI: 10.1053/j.gastro.2019.03.015
20. Yilmaz I., Dolar M.E., Ozpinar H. Effect of administering kefir on the changes in fecal microbiota and symptoms of inflammatory bowel disease: A randomized controlled trial. Turk. J. Gastroenterol. 2019; 30: 242–253. DOI: 10.5152/tjg.2018.18227
21. Curciarello R., Canziani K.E., Salto I., Romero E.B., Rocca A., Doldan I., et al. Probiotic Lactobacilli isolated from kefir promote down-regulation of inflammatory lamina propria T cells from patients with active IBD. Front. Pharmacol. 2021; 12: 658026. DOI: 10.3389/fphar.2021.658026
22. Di Rosa C., Di Francesco L., Spiezia C., Khazrai Y.M. Effects of animal and vegetable proteins on gut microbiota in subjects with overweight or obesity. Nutrients. 2023; 15: 2675. DOI: .10.3390/nu15122675
23. Abbeele P.V.D., Ghyselinck J., Marzorati M., Koch A-M., Lambert W., Michiels J. et al. The effect of amino acids on production of SCFA and bCFA by members of the porcine colonic microbiota. Microorganisms. 2022; 10: 762. DOI: 10.3390/microorganisms10040762
24. Kovaleva T.S., Kryukova O.N., Ezhova A.V., Yakovleva S.F. Effect of dietary intake on the composition of the intestinal microbiota. Vestnik VGUIT. 2024; 86 (3): 51–58. (in Russ). DOI: 10.20914/2310-1202-2024-3-51-58
25. Agus A., Planchais J., Sokol H. Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe. 2018; 23: 716–724. DOI: 0.1016/j.chom.2018.05.003
26. Zhu C., Sawrey-Kubicek L., Beals E., Rhodes C.H., Houts H.E., Sacchi R., et al. Human gut microbiome composition and tryptophan metabolites were changed differently by fast food and Mediterranean diet in 4 days: A pilot study. Nutr. Res. 2020; 77: 62–72. DOI: 10.1016/j.nutres.2020.03.005
27. Tian Q.B., Chen S.J., Xiao L.J., Xie J.Q., Zhao H.B., Zhang X. Potential effects of nutrition-induced alteration of gut microbiota on inflammatory bowel disease: A review. J. Dig. Dis. 2024; 25: 78–90. DOI: 10.1111/1751-2980.13256
28. Boneh R.S., Van Limbergen J., Wine E., Assa A., Shaoul R., Milman P., et al. Dietary therapies induce rapid response and remission in pediatric patients with active Crohn’s disease. Clin. Gastroenterol. Hepatol. 2020; 19: 752–759. DOI: 10.1016/j.cgh.2020.05.026
29. Smyth M., Lunken G., Jacobson K. Insights into inflammatory bowel disease and effects of dietary fatty acid intake with a focus on polyunsaturated fatty acids using preclinical models. J. Can. Assoc. Gastroenterol. 2024; 7: 104–114. DOI: 10.1016/j.cgh.2020.05.026
30. Yorulmaz E., Yorulmaz H., Gökmen E.S., Altınay S., Küçük S.H., Zengi O., et al. Therapeutic effectiveness of rectally administered fish oil and mesalazine in trinitrobenzenesulfonic acid-induced colitis. Biomed. Pharmacother. 2019; 118: 109247. DOI: 10.1016/j.cgh.2020.05.026
31. Scaioli E., Sartini A., Bellanova M., Campieri M., Bazzoli F., Belluzzi A. Eicosapentaenoic acid reduces fecal levels of calprotectin and prevents relapse in patients with ulcerative colitis. Clin. Gastroenterol. Hepatol. 2018; 16: 1268–1275.e2. DOI: 10.1016/j.cgh.2020.05.026
32. Ajabnoor S.M., Thorpe G., Abdelhamid A., Hooper L. Longterm effects of increasing omega-3, omega-6 and total polyunsaturated fats on inflammatory bowel disease and markers of inflammation: A systematic review and meta-analysis of randomized controlled trials. Eur. J. Nutr. 2021; 60: 2293– 2316. DOI: 10.1007/s00394-020-02413-y
33. Dodda D., Chhajed R., Mishra J., Padhy M. Targeting oxidative stress attenuates trinitrobenzene sulphonic acid induced inflammatory bowel disease like symptoms in rats: Role of quercetin. Indian J. Pharmacol. 2014; 46: 286–291. DOI: 10.4103/0253-7613.132160
34. Jia H., Zhang Y., Si X., Jin Y., Jiang D., Dai Zh., et al. Quercetin alleviates oxidative damage by activating nuclear factor erythroid 2-related factor 2 signaling in porcine enterocytes. Nutrients. 2021; 13: 375. DOI: 10.3390/nu13020375
35. Lin R., Piao M., Song Y. Dietary quercetin increases colonic microbial diversity and attenuates colitis severity in citrobacter rodentium-infected mice. Front. Microbiol. 2019; 10: 1092. DOI: 10.3389/fmicb.2019.01092
36. Riemschneider S., Hoffmann M., Slanina U., Weber K., Hauschildt S., Lehmann J. Indol-3-Carbinol and Quercetin ameliorate chronic dss-induced colitis in C57BL/6 mice by AhR-mediated anti-inflammatory mechanisms. Int. J. Env. Res. Public Health. 2021; 18: 2262. DOI: 10.3390/ijerph18052262
37. Ambati R.R., Phang S.-M., Ravi S., Aswathanarayana R.G. Astaxanthin: sources, extraction, stability, biological activities and its commercial applications — a review. Mar. Drugs. 2014; 12: 128–152. DOI: 10.3390/md12010128
38. Zhang C., Xu Y., Wu S., Zheng W., Song S., Ai Ch. Fabrication of astaxanthin-enriched colon-targeted alginate microspheres and its beneficial effect on dextran sulfate sodium-induced ulcerative colitis in mice. Int. J. Biol. Macromol. 2022; 205: 396–409. DOI: 10.1016/j.ijbiomac.2023.128494
39. Luo M., Yuan Q., Liu M., Song X., Xu Y., Zhang T. et al. Astaxanthin nanoparticles ameliorate dextran sulfate sodiuminduced colitis by alleviating oxidative stress, regulating intestinal flora, and protecting the intestinal barrier. Food Funct. 2023; 14: 9567–9579. DOI: 10.1039/d3fo03331g
40. Shokri-mashhadi N., Tahmasebi M., Mohammadi-asl J., Zakerkish M., Mohammadshahi M. The antioxidant and anti-inflammatory effects of astaxanthin supplementation on the expression of miR-146a and miR-126 in patients with type 2 diabetes mellitus: A randomised, double-blind, placebocontrolled clinical trial. Int. J. Clin. Pract. 2021; 75: e14022. DOI: 10.1111/ijcp.14022
41. Narayanaswam N.K., Caston E., Kumar R.C.S., Vijayakumar T.M., Vanangamudi V.S., Pankaj N., et al. A randomized interventional clinical trial assessing the safety and effectiveness of PeaNoc XL tablets in managing joint pain and inflammation in arthritis patients. F1000Research. 2023; 12: 895. DOI: 10.12688/f1000research.138477.1
42. Rostami S., Alyasin A., Saedi M., Nekoonam S., Khodarahmian M., Moeini A. et al. Astaxanthin ameliorates inflammation, oxidative stress, and reproductive outcomes in endometriosis patients undergoing assisted reproduction: A randomized, tripleblind placebo-controlled clinical trial. Front. Endocrinol. 2023; 14: 1144323. DOI: 10.3389/fendo.2023.1144323
43. Story E.N., Kopec R.E., Schwartz S.J., Harris G.K. An update on the health effects of tomato lycopene. Annu. Rev. Food Sci. Technol. 2010; 1: 189–210. DOI: 10.1146/annurev.food.102308.124120
44. Yue Y., Shi M., Song X., Ma C., Li D., Hu X. Lycopene ameliorated DSS-induced colitis by improving epithelial barrier functions and inhibiting the escherichia coli adhesion in mice. J. Agric. Food Chem. 2024; 72: 5784–5796. DOI: 10.1021/acs.jafc.3c09717
45. Nalyotov A.V., Khavkin A.I., Matsynin N.A. Curcumin — prospects for use In the treatment of diseases of the digestive system. Children’s medicine of the North-West. 2024; 12 (3): 49–56. (in Russ.)
46. Shrainer E.V., Nikolaychuk K.M., Khavkin A.I., Veremenko A.S., Levchenko I.D., Platonova G.Ya., et al. Pharmacodynamic characteristics of curcumin. Jeksperimental’naja i klinicheskaja gastrojenterologija. 2024; (8): 291–306. (in Russ). DOI: 10.31146/1682-8658-ecg-228-8-291-306
47. Khavkin A.I, Nalyotov A.V. Curcumin as a novel trend in adjunctive therapy for ulcerative colitis. Pediatricheskaja farmakologija. 2024; 21 (6): 534–538. (in Russ). DOI: 10.15690/pf.v21i6.2840
48. Zheng T., Wang X., Chen Z., Ahmad R., Challa A., Liu G. Efficacy of adjuvant curcumin therapy in ulcerative colitis: A meta-analysis of randomized controlled trials. J. Gastroenterol. Hepatol. 2020; 35: 722–729. DOI: 10.1111/jgh.14911
49. Coelho M.R., Romi M.D., Ferreira D.M.T.P., Zaltman C., Soares-Mota M. The use of curcumin as a complementary therapy in ulcerative colitis: A systematic review of randomized controlled clinical trials. Nutrients. 2020; 12: 2296. DOI: 10.3390/nu12082296
50. Goulart R.A., Barbalho S.M., Rubira C.J., Araújo A.C., Lima V.M., Leoni B.R., et al. Curcumin therapy for ulcerative colitis remission: Systematic review and meta-analysis. Expert Rev. Gastroenterol. Hepatol. 2020; 14: 1171–1179. DOI: 10.1080/17474124.2020.1808460
51. Yin J., Wei L., Wang N., Li X., Miao M. Efficacy and safety of adjuvant curcumin therapy in ulcerative colitis: A systematic review and meta-analysis. J. Ethnopharmacol. 2022; 289: 115041. DOI: 10.1016/j.jep.2022.115041
52. Khavkin A.I., Nalyotov A.V., Masyuta D.I., Makhmutov R.F. Role of vitamin D in the pathogenesis of inflammatory bowel diseases: literature review. Voprosy sovremennoj pediatrii. 2024; 23 (2): 58–62. (Ii Russ). DOI: 10.15690/vsp.v23i2.2722
53. Boughanem H., Ruiz-Limón P., Pilo J., LisbonaMontañez J.M., Tinahones F.J., Indias I.M., et al. Linking serum vitamin D levels with gut microbiota after 1-year lifestyle intervention with Mediterranean diet in patients with obesity and metabolic syndrome: A nested cross-sectional and prospective study. Gut Microbes. 2023; 15: 2249150. DOI: 10.1080/19490976.2023.224915
54. Morvaridi M., Jafarirad S., Seyedian S.S., Alavinejad P., Cheraghian B. The effects of extra virgin olive oil and canola oil on inflammatory markers and gastrointestinal symptoms in patients with ulcerative colitis. Eur. J. Clin. Nutr. 2020; 74: 891–899. DOI: 10.1038/s41430-019-0549-z
55. Nalyotov A.V., Khavkin A.I., Matsynina M.A., Moskaljuk O.N. Nuts are an important component of a healthy diet. Voprosy dietologii. 2024; 14(4): 42–47. (in Russ). DOI: 10.20953/2224-5448-2024-4-42-47
56. Viale P.H. The benefits of nuts for cancer prevention. J. Adv. Pract. Oncol. 2019; 10: 102–103
57. Bamberger C., Rossmeier A., Lechner K., Wu L., Waldmann E., Fischer S., et al. A walnut-enriched diet affects gut microbiome in healthy caucasian subjects: a randomized, controlled trial. Nutrients. 2018; 10: 244. DOI: 10.3390/nu10020244
58. Nunes S., Danesi F., Del Rio D., Silva P. Resveratrol and inflammatory bowel disease: The evidence so far. Nutr. Res. Rev. 2018; 31: 85–97. DOI: 10.1017/S095442241700021X
59. White B.A., Ramos G.P., Kane S. The Impact of Alcohol in Inflammatory Bowel Diseases. Inflamm. Bowel Dis. 2021; 28: 466–473. DOI: 10.1093/ibd/izab089
60. Scheffers L.E., Vos I.K., Utens E., Dieleman G., Walet S., Escher J.C. et al. Physical training and healthy diet improved bowel symptoms, quality of life, and fatigue in children with inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 2023; 77: 214–221. DOI: 10.1097/MPG.0000000000003816
Review
For citations:
Nalyotov A.V., Khavkin A.I., Matsynin A.N. Prospects of using the mediterranean diet in the treatment of inflammatory bowel diseases. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2025;70(6):21-28. (In Russ.) https://doi.org/10.21508/1027-4065-2025-70-6-21-28
Views:
27
JATS XML
Email this article 